Connect with us

Health

COVID-19: Monoclonal antibody combo reduces hospitalization – Medical News Today

A large Mayo Clinic study finds that treating COVID-19 patients with two monoclonal antibodies — casirivimab and imdevimab —…

Published

on

Article feature image

  • A new study finds that a combination of two monoclonal antibodies can help high-risk COVID-19 patients avoid being hospitalized.
  • In a study involving nearly 1,400 people with mild to moderate cases of COVID-19, significantly fewer individuals receiving antibody…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending